MONEYJohnson & Johnson will stop selling talc-based baby powder around the world...

Johnson & Johnson will stop selling talc-based baby powder around the world in 2023

Its talc-based powder, which hasn’t been bought in america and Canada since 2020, is on the heart of tens of hundreds of lawsuits filed by ladies who’ve developed ovarian most cancers after utilizing common talcum powder

Johnson & Johnson says it stays assured within the security of the product. However, in an announcement Friday, the corporate mentioned it could cease promoting talc-based powder world wide subsequent 12 months as a part of a “worldwide portfolio evaluation.”

“We constantly consider and optimize our portfolio to greatest place the enterprise for long-term development,” the corporate mentioned in an announcement. “This transition will assist simplify our product choices, ship sustainable innovation, and meet the wants of our customers, clients and evolving international traits.”

A handful of talcum powder firms have put warning labels on their merchandise, however Johnson & Johnson (JNJ) argued such a label could be complicated, as a result of it stood by its product. Some scientific research have proven that girls have an elevated threat of ovarian most cancers with talc use within the genital space, however others don’t.
Lawsuits have been filed in opposition to the corporate alleging that asbestos in its talcum powder causes most cancers. A St. Louis jury delivered a $4.7 billion verdict in opposition to the corporate in 2018, saying the corporate was negligent and didn’t warn customers about potential well being dangers from its child powder.

“Our place on the protection of our beauty talc stays unchanged. We stand firmly behind the a long time of unbiased scientific evaluation by medical specialists world wide that confirms talc-based Johnson’s Child Powder is secure, doesn’t include asbestos, and doesn’t trigger most cancers,” it mentioned in Friday’s announcement.

Source link

Exclusive content

Latest article

More article